Atlas Trials

Oral Topotecan With Toripalimab for Patients With Endometrial Cancer

Clinical trial NCT06548763 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06548763
Sponsor
Fudan University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Endometrial Cancer
Start date
2024-11-30
Primary completion
2026-06-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.